SWISS STEM CELL TECHNOLOGY

Cell therapy was developed by a Swiss surgeon, Prof. Dr. Paul Niehans, in 1931, when the first successful experiment was carried out: the patient was cured.

In 1960, An Introduction to Cell Therapy was published, a book that laid the foundations for further scientific research.

Progress over the next few decades, until the 1970s, was rather slow, and some gene therapy trials ended in failure. However, the turning point began in the 1990s.

The most important results of scientific research were obtained in 2005-2013, which laid the foundations for modern methods of treatment. It should be noted that researches are still ongoing, new ways of transporting and storing cells are being discovered, more and more diseases are being treated with the help of cell therapy. Therefore, every year our medical protocol is updated based on international experience, in accordance with US and Swiss standards.

YES, IT IS!

The debates about safety of autologous mesenchymal stem cells (patient's cells) seem more obvious because they are taken from the patient's body, and therefore are 100% accepted by the patient's immune system.

Same as allogeneic cells (donor cells).

Donor mesenchymal stem cells do not cause rejection because they are immunoprivileged and are not recognized by the immune system as a foreign body. Most of the cells overcome the hematoencephalic barrier, so their number when administered is slightly higher than necessary so that the required percentage of cells can enter the organs and tissues affected by the disease.